Advertisements



This Biotech Just Had a $903 Million IPO—And It’s Disappointed

Cancer drug maker BeiGene was looking to score $1 billion in its secondary listing in Hon.....»»

Category: europeSource: fortuneAug 2nd, 2018

RA Capital sues ChemoCentryx after biotech company"s $3.9 billion sale to Amgen

The suit comes 19 months after the Peninsula biotech company was sold to Amgen for $3.9 million......»»

Category: topSource: bizjournalsMay 7th, 2024

Jennifer Doudna co-founded Peninsula biotech lands CRISPR gene-editing pact with Regeneron

The deal, which could pay the Peninsula company a $100 million upfront and up to $370 million per target, is the third aimed at assembling CRISPR's components in the body......»»

Category: topSource: bizjournalsApr 25th, 2024

Former CHOP CEO and Spark co-founder to lead new biotech startup launched with $54M in funding

Altschuler said the $54 million in funding "will put rocket boosters under Corner's pioneering work.".....»»

Category: topSource: bizjournalsApr 23rd, 2024

Duke spin-out raises $7 million to advance gene therapy purification technology

A Durham biotech startup that spun out of Duke University has raised $7 million in seed funding to scale up its purification technology for biotherapeutics. Isolere Bio Inc. announced Wednesday it has raised $7 million in equity from lead inve.....»»

Category: topSource: bizjournalsMay 5th, 2021

Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City

A gene therapy startup that launched last summer has raised $120 million toward expanding its biotech manufacturing capacity in Grove City. It's the largest Series B financing in Ohio history, according to PitchBook......»»

Category: topSource: bizjournalsApr 29th, 2021

UBS takes a $744 million hit from Archegos in the first quarter, as the fund"s implosion continues to hurt banks

"We are all clearly disappointed and are taking.....»»

Category: personnelSource: nytApr 27th, 2021

Explosive Bay Area biotech raises $500M in upsized IPO

The eight-year-old company has hired nearly 800 people, raised more than $870 million and plans to move into one of the East Bay's most iconic spaces as it rolls out an atypical range of products faster, cheaper and in a more environmentally safe way......»»

Category: personnelSource: nytApr 23rd, 2021

Biomea Fusion"s upsized IPO prices at top of expected range, to value the biotech at $464 million

Biomea Fusion Inc. was set to go public Friday, as the California-.....»»

Category: topSource: marketwatchApr 16th, 2021

Beauty biotech Amyris makes two deals with AI, Gen-Z upside

The company has invested about $12 million in acquiring and developing new brands this year, the CEO said......»»

Category: topSource: bizjournalsApr 15th, 2021

Biotech company spun out of Ohio State University research raises $116M in latest round

When it was founded back in 2018, Entrada raised $59 million, which was the largest amount raised in an initial financing round for an OSU startup......»»

Category: topSource: bizjournalsApr 5th, 2021

Another Maryland biotech has filed to go public. Here are the details.

The company will look to raise $100 million in its initial public offering......»»

Category: topSource: bizjournalsJan 20th, 2021

Sana Biotechnology aims to raise $150M in IPO

Sana Biotechnology Inc. intends to go public this year, according to a Wednesday filing with the U.S. Securities and Exchange Commission. The preclinical biotech is looking to raise up to $150 million on the Nasdaq under the symbol SANA. The ge.....»»

Category: topSource: bizjournalsJan 13th, 2021

Portland biotech company has big plans for its cardiovascular drugs

Aronora has secured $25 million in grants but is seeking a partner to take its drug candidates into Phase 3 clinical trials......»»

Category: topSource: bizjournalsJan 8th, 2021

A new JPM: Biotech"s big meeting week goes virtual with swag and questions

The week of the J.P. Morgan Healthcare Conference, starting Monday, typically packs a $52 million economic impact for San Francisco......»»

Category: topSource: bizjournalsJan 8th, 2021

SomaLogic adds $81M to Series A financing round

The Boulder-based biotech closed on an initial $121 million Series A round in November......»»

Category: topSource: bizjournalsDec 22nd, 2020

Biotech firm Calyxt inks big soybean deal with Archer-Daniels-Midland

Terms of the deal weren't disclosed, but Calyxt said it is selling over 4 million bushels of its high oleic soybean grain to ADM, which could be worth over $46 million......»»

Category: topSource: bizjournalsDec 14th, 2020

U.S. buys another 100 million COVID-19 vaccine candidate doses: Moderna

Biotech company Moderna Inc. said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brin.....»»

Category: topSource: marketwatchDec 13th, 2020

St. Louis biotech startup snags $20M investment

St. Louis-based biotechnology startup C2N Diagnostics, which has created a blood test designed to detect Alzheimer's disease, said Thursday it has received a $20 million investment from a Minneapolis-based philanthropic organization. The investment was.....»»

Category: topSource: bizjournalsMay 14th, 2020

Seattle biotech CEO keeps a watchful eye on the market for potential IPO

Its recent $5 million funding round lays the groundwork for developing its pipeline......»»

Category: topSource: bizjournalsMay 12th, 2020

Orgenesis First Quarter 2020 Revenue Increases 348% to $1.9 Million Reflecting Success of CGT Biotech Platform

GERMAN.....»»

Category: earningsSource: benzingaMay 11th, 2020